Drug: |
Nivolumab + Ipilimumab |
|||
---|---|---|---|---|
Trial: |
Nivolumab With or Without Ipilimumab in Treating Patients With Metastatic or Unresectable Sarcoma |
|||
Conditions: | Gastrointestinal Stromal Tumor | |||
Trial Status: |
Completed |
Memorial Sloan Kettering1275 York Ave |
Principal Investigator: |
Sandra D'Angelo, MD |
---|---|
Contact: |
Sandra, D'Angelo, MD 212-639-7202 |
Activation Status of this Site: |
Closed |
Notes about this Site: |
|
Memorial Sloan Kettering Website: |
http://www.mskcc.org/mskcc/html/2270.cfm?Tab=All |
Use the plus (+) and minus (-) controls to zoom in/out.
Click and drag the map or use the arrows to move (pan) the map.
Tip: Click the marker before zooming and the map will stay centered on the marker as you zoom.